Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2019

01-12-2019 | Esophageal Cancer | Thoracic Oncology

The Influence of the Perioperative Nutritional Status on the Survival Outcomes for Esophageal Cancer Patients with Neoadjuvant Chemotherapy

Authors: Makoto Hikage, MD, PhD, Yusuke Taniyama, MD, PhD, Tadashi Sakurai, MD, PhD, Chiaki Sato, MD, PhD, Kai Takaya, MD, PhD, Hiroshi Okamoto, MD, PhD, Takuro Konno, MD, PhD, Naoto Ujiie, MD, PhD, Takeshi Naitoh, MD, PhD, Michiaki Unno, MD, PhD, Takashi Kamei, MD, PhD

Published in: Annals of Surgical Oncology | Issue 13/2019

Login to get access

Abstract

Background

Studies have shown a variety of nutritional indices to be prognostic predictors for esophageal cancer patients. However, which nutritional index should be used and when it should be measured during the perioperative period remain unclear. This study attempted to clarify the details surrounding predictive nutritional evaluation by assessing the longitudinal data of serologic indices in perioperative esophageal cancer patients.

Methods

The study included 141 esophageal cancer patients who underwent neoadjuvant chemotherapy after radical esophagectomy at Tohoku University Hospital from April 2008 to December 2017. The nutritional status was retrospectively assessed during the perioperative period, and the prognostic factors related to survival were analyzed.

Results

Use of the controlling nutritional status (CONUT) score showed that malnutrition occurred only from 14 days after surgery in most cases. Use of the prognostic nutritional index (PNI) showed that the ratio of malnutrition increased gradually from presurgery to 14 days after surgery. The timing of malnutrition that affected survival was 14 days after surgery with the CONUT score and presurgery and 4 months after surgery with the PNI. A multivariable analysis of independent prognostic factors predicting survival identified malnutrition 14 days after surgery with the CONUT score and a low PNI before surgery, invasion depth of the primary lesion, and node metastasis.

Conclusions

Malnutrition occurring during the perioperative state of esophageal cancer was shown to be a survival prognostic factor. Development of an optimal nutritional intervention is recommended for esophageal cancer patients to prevent malnutrition both before and after surgery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187–96.CrossRef Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187–96.CrossRef
2.
go back to reference Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRef
3.
go back to reference Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.CrossRef Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.CrossRef
4.
go back to reference Nagaraja V, Cox MR, Eslick GD. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2014;5:119–26.PubMedPubMedCentral Nagaraja V, Cox MR, Eslick GD. Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol. 2014;5:119–26.PubMedPubMedCentral
5.
go back to reference Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623–50.CrossRef Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623–50.CrossRef
6.
go back to reference Capra S, Ferguson M, Ried K. Cancer: impact of nutrition intervention outcome: nutrition issues for patients. Nutrition. 2001;17:769–72.CrossRef Capra S, Ferguson M, Ried K. Cancer: impact of nutrition intervention outcome: nutrition issues for patients. Nutrition. 2001;17:769–72.CrossRef
7.
go back to reference Lanuti M, DeDelva P, Morse CR, et al. Management of delayed gastric emptying after esophagectomy with endoscopic balloon dilatation of the pylorus. Ann Thorac Surg. 2011;91:1019–24.CrossRef Lanuti M, DeDelva P, Morse CR, et al. Management of delayed gastric emptying after esophagectomy with endoscopic balloon dilatation of the pylorus. Ann Thorac Surg. 2011;91:1019–24.CrossRef
8.
go back to reference Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status: first validation in a hospital population. Nutr Hosp. 2005;20:38–45.PubMed Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status: first validation in a hospital population. Nutr Hosp. 2005;20:38–45.PubMed
9.
go back to reference Onodera T, Goseki N, Kosakim G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Zasshi. 1984;85:1001–5. Onodera T, Goseki N, Kosakim G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Zasshi. 1984;85:1001–5.
10.
go back to reference Yoshida N, Baba Y, Shigaki H, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016;40:1910–7.CrossRef Yoshida N, Baba Y, Shigaki H, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016;40:1910–7.CrossRef
11.
go back to reference Yoshida N, Harada K, Baba Y, et al. Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2017;402:333–41.CrossRef Yoshida N, Harada K, Baba Y, et al. Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2017;402:333–41.CrossRef
12.
go back to reference Nakatani M, Migita K, Matsumoto S, et al. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30:1–7.CrossRef Nakatani M, Migita K, Matsumoto S, et al. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30:1–7.CrossRef
13.
go back to reference Matsumoto H, Okamoto Y, Kawai A, et al. Prognosis prediction for postoperative esophageal cancer patients using Onodera’s Prognostic Nutritional Index. Nutr Cancer. 2017;69:849–54.CrossRef Matsumoto H, Okamoto Y, Kawai A, et al. Prognosis prediction for postoperative esophageal cancer patients using Onodera’s Prognostic Nutritional Index. Nutr Cancer. 2017;69:849–54.CrossRef
16.
go back to reference Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Wiley, Oxford; 2017. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Wiley, Oxford; 2017.
17.
go back to reference Ichikawa H, Miyata G, Miyazaki S, et al. Esophagectomy using a thoracoscopic approach with an open laparotomic or hand-assisted laparoscopic abdominal stage for esophageal cancer: analysis of survival and prognostic factors in 315 patients. Ann Surg. 2013;257:873–85.CrossRef Ichikawa H, Miyata G, Miyazaki S, et al. Esophagectomy using a thoracoscopic approach with an open laparotomic or hand-assisted laparoscopic abdominal stage for esophageal cancer: analysis of survival and prognostic factors in 315 patients. Ann Surg. 2013;257:873–85.CrossRef
18.
go back to reference Teshima J, Miyata G, Kamei T, et al. Comparison of short-term outcomes between prone and lateral decubitus positions for thoracoscopic esophagectomy. Surg Endosc. 2015;29:2756–62.CrossRef Teshima J, Miyata G, Kamei T, et al. Comparison of short-term outcomes between prone and lateral decubitus positions for thoracoscopic esophagectomy. Surg Endosc. 2015;29:2756–62.CrossRef
19.
go back to reference Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th edition: parts II and III. Esophagus. 2017;14:37–65.CrossRef Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 11th edition: parts II and III. Esophagus. 2017;14:37–65.CrossRef
21.
go back to reference Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.CrossRef
22.
go back to reference Chen P, Han L, Wang C, et al. Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy. Oncotarget. 2017;8:41605–19.PubMedPubMedCentral Chen P, Han L, Wang C, et al. Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy. Oncotarget. 2017;8:41605–19.PubMedPubMedCentral
23.
go back to reference Lee H, Jeong CW, Kwak C, et al. Preoperative cholesterol level is associated with worse pathological outcomes and postoperative survival in localized renal cell carcinoma patients: a propensity score-matched study. Clin Genitourin Cancer. 2017;15:e935–41.CrossRef Lee H, Jeong CW, Kwak C, et al. Preoperative cholesterol level is associated with worse pathological outcomes and postoperative survival in localized renal cell carcinoma patients: a propensity score-matched study. Clin Genitourin Cancer. 2017;15:e935–41.CrossRef
24.
go back to reference Lee SH, Lee JY, Hong TH, Kim BO, Lee YJ, Lee JG. Severe persistent hypocholesterolemia after emergency gastrointestinal surgery predicts in-hospital mortality in critically ill patients with diffuse peritonitis. PLoS ONE. 2018;13:e0200187.CrossRef Lee SH, Lee JY, Hong TH, Kim BO, Lee YJ, Lee JG. Severe persistent hypocholesterolemia after emergency gastrointestinal surgery predicts in-hospital mortality in critically ill patients with diffuse peritonitis. PLoS ONE. 2018;13:e0200187.CrossRef
25.
go back to reference Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.CrossRef Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.CrossRef
26.
go back to reference Goense L, Meziani J, Ruurda JP, van Hillegersberg R. Impact of postoperative complications on outcomes after oesophagectomy for cancer. Br J Surg. 2019;106:111–9.CrossRef Goense L, Meziani J, Ruurda JP, van Hillegersberg R. Impact of postoperative complications on outcomes after oesophagectomy for cancer. Br J Surg. 2019;106:111–9.CrossRef
27.
go back to reference Kanekiyo S, Takeda S, Iida M, et al. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy. Nutrition. 2019;59:96–102.CrossRef Kanekiyo S, Takeda S, Iida M, et al. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy. Nutrition. 2019;59:96–102.CrossRef
28.
go back to reference Wu N, Chen G, Hu H, Pang L, Chen Z. Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015;67:481–5.CrossRef Wu N, Chen G, Hu H, Pang L, Chen Z. Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015;67:481–5.CrossRef
29.
go back to reference Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8:1025–9.CrossRef Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8:1025–9.CrossRef
30.
go back to reference Yamana I, Takeno S, Shimaoka H, et al. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma: retrospective cohort study. Int J Surg. 2018;56:44–8.CrossRef Yamana I, Takeno S, Shimaoka H, et al. Geriatric Nutritional Risk Index as a prognostic factor in patients with esophageal squamous cell carcinoma: retrospective cohort study. Int J Surg. 2018;56:44–8.CrossRef
31.
go back to reference Mitzman B, Schipper PH, Edwards MA, Kim S, Ferguson MK. Complications after esophagectomy are associated with extremes of body mass index. Ann Thorac Surg. 2018;106:973–80.CrossRef Mitzman B, Schipper PH, Edwards MA, Kim S, Ferguson MK. Complications after esophagectomy are associated with extremes of body mass index. Ann Thorac Surg. 2018;106:973–80.CrossRef
32.
go back to reference Wightman SC, Posner MC, Patti MG, et al. Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017;30:1–6.CrossRef Wightman SC, Posner MC, Patti MG, et al. Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017;30:1–6.CrossRef
33.
go back to reference Ida S, Watanabe M, Karashima R, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.CrossRef Ida S, Watanabe M, Karashima R, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.CrossRef
34.
go back to reference Reisinger KW, Bosmans JW, Uittenbogaart M, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol. 2015;22:4445–52.CrossRef Reisinger KW, Bosmans JW, Uittenbogaart M, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol. 2015;22:4445–52.CrossRef
35.
go back to reference Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol. 2015;22:4432–7.CrossRef Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol. 2015;22:4432–7.CrossRef
36.
go back to reference Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2017;43:478–84.CrossRef Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2017;43:478–84.CrossRef
37.
go back to reference Miyata H, Yano M, Yasuda T, et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr. 2012;31:330–6.CrossRef Miyata H, Yano M, Yasuda T, et al. Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Clin Nutr. 2012;31:330–6.CrossRef
38.
go back to reference Taniguchi H, Sasaki T, Fujita H, et al. Effects of goal-directed fluid therapy on enhanced postoperative recovery: an interventional comparative observational study with a historical control group on oesophagectomy combined with ERAS program. Clin Nutr ESPEN. 2018;23:184–93.CrossRef Taniguchi H, Sasaki T, Fujita H, et al. Effects of goal-directed fluid therapy on enhanced postoperative recovery: an interventional comparative observational study with a historical control group on oesophagectomy combined with ERAS program. Clin Nutr ESPEN. 2018;23:184–93.CrossRef
Metadata
Title
The Influence of the Perioperative Nutritional Status on the Survival Outcomes for Esophageal Cancer Patients with Neoadjuvant Chemotherapy
Authors
Makoto Hikage, MD, PhD
Yusuke Taniyama, MD, PhD
Tadashi Sakurai, MD, PhD
Chiaki Sato, MD, PhD
Kai Takaya, MD, PhD
Hiroshi Okamoto, MD, PhD
Takuro Konno, MD, PhD
Naoto Ujiie, MD, PhD
Takeshi Naitoh, MD, PhD
Michiaki Unno, MD, PhD
Takashi Kamei, MD, PhD
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07742-9

Other articles of this Issue 13/2019

Annals of Surgical Oncology 13/2019 Go to the issue